N/A
Manufactured by Sandoz Inc
49,809 FDA adverse event reports analyzed
Last updated: 2026-04-14
CIPROFLOXACIN HYDROCHLORIDE AND HYDROCORTISONE is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Sandoz Inc. The most commonly reported adverse reactions for CIPROFLOXACIN HYDROCHLORIDE AND HYDROCORTISONE include DRUG HYPERSENSITIVITY, PAIN, NEUROPATHY PERIPHERAL, NAUSEA, DIARRHOEA. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for CIPROFLOXACIN HYDROCHLORIDE AND HYDROCORTISONE.
Out of 20,505 classified reports for CIPROFLOXACIN HYDROCHLORIDE AND HYDROCORTISONE:
The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.
Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.
This profile reflects 49,809 FDA FAERS reports that mention CIPROFLOXACIN HYDROCHLORIDE AND HYDROCORTISONE. Reporting is voluntary and does not prove that the drug caused any listed event.
Frequently reported terms in FAERS include DRUG HYPERSENSITIVITY, PAIN, NEUROPATHY PERIPHERAL, NAUSEA, DIARRHOEA, ARTHRALGIA. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.
Labeling and FAERS entries often list Sandoz Inc in connection with CIPROFLOXACIN HYDROCHLORIDE AND HYDROCORTISONE. Always verify the specific product and NDC with your pharmacist.